MSME (Udyam registered) Ministry of MSME
- Category
- Small (2021-22)
- Udyam number
- UDYAM-TS-20-0007144
Paradigm Medivision Private Limited
Paradigm Medivision Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2019
₹12.61 Cr
▼ 21% YoY
Net profit · FY 2019
₹5.21 Lakh
Net margin 0.4%
EBITDA · FY 2019
₹1.64 Cr
EBITDA margin 13%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.08 Cr
Issued & subscribed
Open charges
₹2.04 Cr
Satisfied ₹10.18 Cr
Company age
22 yrs
Est. 2004
Directors on board
2
As per MCA filings
About Paradigm Medivision Private Limited
Data last updated:
Paradigm Medivision Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 June 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PTC043554. Its GSTIN is 36AADCP2993D1ZD (Telangana). The company holds 5 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.08 Cr. It is led by directors Vedprakash Vyas and Jyothi Vyas.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Plot No. 157 # 5 – 5 – 35/136B Ida Prashanthi Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2019, the company reported a revenue of ₹12.61 Cr, a decline of 21% compared to the previous year. For the same year it recorded a net profit of ₹5.21 Lakh (net margin 0.4%) and EBITDA of ₹1.64 Cr (EBITDA margin 13%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years.
As per MCA filings, the company has open charges of ₹2.04 Cr and satisfied charges of ₹10.18 Cr on record. Court records list 15 cases involving the company, including 3 filed by the company and 12 filed against it; 3 cases are pending.
Paradigm Medivision Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0007144). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24239TG2004PTC043554
Registration Number 043554
Incorporation Date 29 June 2004
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2019
Date of Balance Sheet 31 March 2019
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0007144
CIN history
Paradigm Medivision has one previous CIN (Corporate Identification Number): U24239AP2004PTC043554. The current CIN is U24239TG2004PTC043554, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PTC043554 | Current |
| U24239AP2004PTC043554 | Previous |
Recognitions & Rankings of Paradigm Medivision
Contact details
Paradigm Medivision Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No. 157 # 5 – 5 – 35/136B Ida Prashanthi Nagar Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Paradigm Medivision Private Limited, buy the company report.
Comprehensive company report
Paradigm Medivision Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Paradigm Medivision is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Paradigm Medivision Private Limited, buy the company report.
Financials of Paradigm Medivision Private Limited
FY 2019 filings availableParadigm Medivision Private Limited reported revenue of ₹12.61 Cr (down 21% YoY) for FY 2019.
Revenue · FY 2019
₹12.61 Cr ▼ 21%
Net profit · FY 2019
₹5.21 Lakh margin 0.4%
EBITDA · FY 2019
₹1.64 Cr margin 13%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 21%
3 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 7%
3 years · compounded
▲ 13%
Revenue fell 21% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹12.61 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.64 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.21 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Paradigm Medivision Private Limited, buy the company report.
Board of directors of Paradigm Medivision Private Limited
Paradigm Medivision has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vedprakash Vyas Also directs: Totus Health Care (India) Limited | Additional Director | 18 Aug 2020 | 6 Years 2 Months | Current |
| Jyothi Vyas Also directs: Totus Health Care (India) Limited, Bravespaces Creative India LLP | Additional Director | 01 Apr 2021 | 5 Years 6 Months | Current |
Peer comparison
Paradigm Medivision Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avansdose Pharmatech Private Limited | ₹12.71 Cr (FY 2025) | -26.0% | Hyderabad, Telangana, India | |||
| Renauxe Pharma India Private Limited | ₹12.66 Cr (FY 2023) | 23.0% | Ernakulam, Kerala, India | |||
| Vitara Cure Private Limited | ₹12.66 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Bansal Pharmachem Pvt. Ltd. | ₹12.62 Cr (FY 2024) | 4.0% | New Delhi, Delhi, India | |||
| Paradigm Medivision Private Limitedthis company | ₹12.61 Cr (FY 2019) | ₹5.21 Lakh | 0.4% | -21.0% | Hyderabad, Telangana, India | |
| Elisa Biotech Private Limited | ₹12.59 Cr (FY 2025) | 17.0% | Delhi, India | |||
| Dolvis Bio Pharma Private Limited | ₹12.57 Cr (FY 2024) | 0.0% | Manimajra, Chandigarh, India | |||
| Saamag Healthcare Professional Management Private Limited | ₹12.57 Cr (FY 2022) | -71.0% | New Delhi, Delhi, India | |||
| Health Medivision Private Limited | ₹12.56 Cr (FY 2024) | -1.0% | Delhi, India |
To see the full peer comparison of Paradigm Medivision Private Limited, buy the company report.
Shareholding
The shareholding of Paradigm Medivision Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Paradigm Medivision Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.04 Cr
Satisfied charges
₹10.18 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Oct 2016 | 100057303 | Syndicate Bank | ₹4.3 Lakh | Open | |
| 13 Apr 2016 | 100021099 | Syndicate Bank | ₹2 Cr | Open | |
| 30 Nov 2010 | 10255869 | Reliance Capital Ltd | ₹36.8 Lakh | Satisfied | |
| 13 Jan 2009 | 10137884 | 3I Infotech Trusteeship Services Limited | ₹8 Cr | Satisfied | |
| 13 Jan 2009 | 10138031 | 3I Infotech Trusteeship Services Limited | ₹1.7 Cr | Satisfied |
To see the full charge records of Paradigm Medivision Private Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
Paradigm Medivision Private Limited has 15 court cases on record: 3 filed by Paradigm Medivision, 12 filed against it. 3 cases are pending and 12 are disposed.
Total cases
15
Filed by the company
3
Filed against the company
12
Pending
3
Disposed
12
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 11 | 2 |
| High courts | 4 | 1 | 1 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Poonawalla Fincorp Limited | Pending |
| High Court, CHANDIGARH (UT) | Criminal miscellaneous application | Filed against the company by M/S Ind Swift Laboratories Limited | Pending |
| District court, Chandigarh | Criminal miscellaneous application | Filed against the company by Ind Swift Laboratories Limited | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Avanse Financial Services Limited | Disposed |
| High Court, CHANDIGARH (UT) | Criminal miscellaneous application | Filed by the company against M/S Ind Swift Laboratories Ltd | Disposed |
To see the full case history of Paradigm Medivision Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Paradigm Medivision Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Paradigm Medivision has 5 GST registrations: 4 active and 1 cancelled or inactive.
Total GSTINs
5
Active
4
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCP2993D1ZD | Telangana | Active | 01 Jul 2017 |
| 07AADCP2993D1ZE | Delhi | Active | 01 Jul 2017 |
| 23AADCP2993D1ZK | Madhya Pradesh | Active | 01 Jul 2017 |
| 27AADCP2993D1ZC | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Paradigm Medivision Private Limited, buy the company report.
Recent activity
Paradigm Medivision Private Limited has 11 board changes on record since 2011: 2 appointments and 9 cessations. The latest: Piyush Kumar Singh ceased to be Director on 05 Apr 2021.
Ceased
Piyush Kumar Singh ceased to be Director.
Appointed
Jyothi Vyas was appointed as Additional Director.
Ceased
Neha Vyas ceased to be Additional Director.
Appointed
Vedprakash Vyas was appointed as Additional Director.
Ceased
Venkata Subba Satynarayana Gajulapally ceased to be Director.
Ceased
Jyothi Vyas ceased to be Director.
Ceased
Vedprakash Vyas ceased to be Whole-Time Director.
AGM
Paradigm Medivision Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records.
Filing
Paradigm Medivision Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Hyderabad.
Charges
A charge with Syndicate Bank of Rs. 2.00 Cr registered on 13 Apr 2016 with Charge ID 100021099 was modified on 28 Mar 2017.
Charges
A charge with Syndicate Bank amounted to Rs. 0.04 Cr with Charge ID 100057303 was registered on 06 Oct 2016.
Charges
A charge with Syndicate Bank amounted to Rs. 2.00 Cr with Charge ID 100021099 was registered on 13 Apr 2016.
18 earlier events are in the company report.
Frequently asked questions
Paradigm Medivision is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 June 2004 (22+ years old) and is registered under CIN U24239TG2004PTC043554.
Paradigm Medivision has 2 current directors:
- Vedprakash Vyas - Additional Director
- Jyothi Vyas - Additional Director
The latest financial statements of Paradigm Medivision on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
The GSTIN of Paradigm Medivision is 36AADCP2993D1ZD, registered in Telangana. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 07AADCP2993D1ZE (Delhi), 23AADCP2993D1ZK (Madhya Pradesh), 27AADCP2993D1ZC (Maharashtra).
The CIN (Corporate Identification Number) of Paradigm Medivision is U24239TG2004PTC043554. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Paradigm Medivision has 15 court cases on record: 3 filed by the company and 12 filed against it. 3 are pending. Most are in the district courts.
Paradigm Medivision was incorporated on 29 June 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Paradigm Medivision by revenue are Avansdose Pharmatech Private Limited, Renauxe Pharma India Private Limited, Vitara Cure Private Limited, Bansal Pharmachem Pvt. Ltd, Elisa Biotech Private Limited and 3 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Piyush Kumar Singh ceased to be Director on 05 Apr 2021. Jyothi Vyas was appointed as Additional Director on 01 Apr 2021. Neha Vyas ceased to be Additional Director on 18 Aug 2020. Paradigm Medivision has 11 board changes on record in total.
Yes, Paradigm Medivision is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0007144).
The registered office of Paradigm Medivision is at Plot No. 157 # 5 – 5 – 35136B Ida Prashanthi Nagar Kukatpally, Hyderabad, Telangana, India – 500072.